Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS.

Rami S Komrokji, Valeria Santini, Amer M Zeidan, Mikkael A Sekeres, Pierre Fenaux, Azra Raza, Moshe Mittelman, Sylvain Thépot, Rena Buckstein, Ulrich Germing, Yazan F Madanat, María Díez-Campelo, David Valcárcel, Anna Jonášová, Souria Dougherty